Cargando…

Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection

Detalles Bibliográficos
Autores principales: Festa, Stefano, De Biasio, Fabiola, Aratari, Annalisa, Papi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444495/
https://www.ncbi.nlm.nih.gov/pubmed/36137935
http://dx.doi.org/10.1016/j.dld.2022.08.038
_version_ 1784783237384503296
author Festa, Stefano
De Biasio, Fabiola
Aratari, Annalisa
Papi, Claudio
author_facet Festa, Stefano
De Biasio, Fabiola
Aratari, Annalisa
Papi, Claudio
author_sort Festa, Stefano
collection PubMed
description
format Online
Article
Text
id pubmed-9444495
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94444952022-09-06 Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection Festa, Stefano De Biasio, Fabiola Aratari, Annalisa Papi, Claudio Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-11 2022-09-06 /pmc/articles/PMC9444495/ /pubmed/36137935 http://dx.doi.org/10.1016/j.dld.2022.08.038 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Festa, Stefano
De Biasio, Fabiola
Aratari, Annalisa
Papi, Claudio
Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title_full Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title_fullStr Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title_full_unstemmed Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title_short Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
title_sort intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant sars-cov-2 infection
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444495/
https://www.ncbi.nlm.nih.gov/pubmed/36137935
http://dx.doi.org/10.1016/j.dld.2022.08.038
work_keys_str_mv AT festastefano intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection
AT debiasiofabiola intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection
AT aratariannalisa intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection
AT papiclaudio intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection